Use the Back button in your browser to see the other results of your search or to select another record.
TENS effects on dysesthesia and quality of life after breast cancer surgery with axilectomy: randomized controlled trial |
Rabelo Mendonca AC, Tirolli Rett M, de Araujo Garcez P, das Virgens Aquino MJ, Vasconcelos Lima L, Melo de Santana J |
Fisioterapia em Movimento [Physical Therapy in Movement] 2017 Dec;30(Suppl 1):S285-S295 |
clinical trial |
7/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: Yes; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
INTRODUCTION: After breast cancer surgery, many women may present quality of life (QOL) impairment due to the presence of discomfort as dysesthesia in the anterolateral region of the chest, armpit and/or medial part of the arm caused by intercostobrachial nerve injury (ICBN). OBJECTIVE: To investigate the effects of Transcutaneous Electrical Nerve Stimulation (TENS) on dysesthesia intensity at the intercostobrachial nerve (ICBN) dermatome and QOL in women after breast cancer surgery. METHODS: A randomized, double-blinded, placebo controlled clinical trial was conducted. Women undergoing axillary lymphadenectomy (AL), with dysesthesia on ICBN dermatome were included. Patients were divided into active and placebo TENS groups. TENS was applied with a frequency of 100 Hz, pulse duration of 100 micro-s and amplitude at the highest sensory intensity tolerable for 20 minutes during 20 sessions, three times a week, on alternating days. In the placebo TENS group, electrical current was delivered only during the first 45 seconds of application. Skin sensitivity was assessed by esthesiometry. Dysesthesia intensity was assessed with a visual analogue scale (VAS) and QOL with the EORTC QLQ-C30 and the specific EORTC QLQ-BR23 which is the Breast Cancer Module. RESULTS: VAS decreased significantly over the 20 sessions in the active TENS group (p < 0.006) and no difference was found between groups. There weren't significant differences in EORTC QLQ-C30 and EORTC QLQ-BR23 after 20 sessions or between groups. CONCLUSION: TENS decreased dysesthesia intensity in the ICBN dermatome after breast cancer surgery, but did not improve quality of life.
|